University of Belgrade / Универзитет у Београду

Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database (2016) Cihoric N, Tsikkinis A, Miguelez CG, Strnad V, Soldatovic I, Ghadjar P, Jeremic B, et al. Journal article European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update (2016) Gossec L, Smolen JS, Ramiro S, De Wit M, Cutolo M, Dougados M, Emery P, et al. Journal article The global spread of HIV-1 subtype B epidemic (2016) Magiorkinis G, Angelis K, Mamais I, Katzourakis A, Hatzakis A, Albert J, Lawyer G, et al. Journal article Ion Release, Hydroxyapatite Conversion, and Cytotoxicity of Boron-Containing Bioactive Glass Scaffolds (2016) Balasubramanian P, Grünewald A, Detsch R, Hupa L, Jokic B, Tallia F, Solanki AK, et al. Journal article, Original article Encapsulation of silver nanowire networks by atomic layer deposition for indium-free transparent electrodes (2015) Göbelt M, Keding R, Schmitt SW, Hoffmann B, Jaeckle S, Latzel M, Radmilovic VV, et al. Journal article 45S5Bioglass®-based scaffolds coated with selenium nanoparticles or with poly(lactide-co-glycolide)/selenium particles: Processing, evaluation and antibacterial activity (2015) Stevanovic M, Filipovic N, Djurdjevic J, Lukic M, Milenkovic M, Boccaccini AR Journal article, Original article The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease (2015) Perez-Rivas LG, Theodoropoulou M, Ferrau F, Nusser C, Kawaguchi K, Stratakis CA, Faucz FR, et al. Journal article Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database (2015) Wirz EG, Jaeger VK, Allanore Y, Riemekasten G, Hachulla E, Distler O, Airò P, et al. Journal article In vitro cell response to Co-containing 1393 bioactive glass (2015) Hoppe A, Brandl A, Bleiziffer O, Arkudas A, Horch RE, Jokic B, Janackovic D, Boccaccini AR Journal article, Original article Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial (2014) Stupp R, Hegi ME, Gorlia T, Erridge SC, Perry J, Hong YK, Aldape KD, et al. Journal article